Literature DB >> 31586606

Pharmacological activities of dehydroepiandrosterone: A review.

Poonam Sahu1, Bina Gidwani2, H J Dhongade3.   

Abstract

Dehydroepiandrosterone (DHEA) is a steroidal hormone secreted by Zonareticularis of the adrenal cortex with a characteristic age related pattern of secretion. These hormones are inactive precursors that are transformed into active sex steroids in peripheral target tissues. These hormones are used for the energy, vitality and the natural support of most bodily functions that involve the endocrine system. DHEA is a 19 carbon steroid hormone, is lipophilic, and can be converted to DHEAs by activity of the enzyme sulphotransferasein the liver and adrenal glands. These are naturally synthesized in our body through cholesterol- pregnenolone pathway and can also be synthesized from various other sources like diosgenin, geniestein, wild yam, soy and cholesterol in laboratory. It serves as an indirect precursor to estrogen and testosterone and other steroid hormones. This hormone progressively declines at the rate of 2% per year. DHEA evidence a large variety of pharmacological activities like antidiabetic, anticancer, anti-allergic, obesity treatment and cardiovascular property. It is beneficial in autoimmune disorders like lupus erythematosus, immune modulation, muscle building and hormonal problems. DHEA is known as an anti-ageing hormone, in osteoporosis and in dementia. It can also be used as a supplement as directed by the physician in various condition.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer; Dehyroepiandrosterone; Lupus erythematosus; Pharmacological activities; Steroids

Mesh:

Substances:

Year:  2019        PMID: 31586606     DOI: 10.1016/j.steroids.2019.108507

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

Review 1.  Antiaging agents: safe interventions to slow aging and healthy life span extension.

Authors:  Ji-Kai Liu
Journal:  Nat Prod Bioprospect       Date:  2022-05-09

2.  TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism.

Authors:  Yan Huang; Xiaohui Zhang; Jie Cheng; Yue Yu; Shumin Wu; Jing Jiao; Linh Tran; Wanru Zhang; Ran Liu; Liuzhen Zhang; Mei Wang; Mengyao Wang; Wenyu Yan; Yilin Wu; Fangtao Chi; Peng Jiang; Xinxiang Zhang; Hong Wu
Journal:  Nat Commun       Date:  2020-04-20       Impact factor: 14.919

3.  Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause.

Authors:  Wojciech Pięta; Roman Smolarczyk
Journal:  Prz Menopauzalny       Date:  2021-01-07

Review 4.  In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism.

Authors:  Valery M Dembitsky
Journal:  Mar Drugs       Date:  2021-11-22       Impact factor: 5.118

5.  From non-targeted to targeted GC-MS metabolomics strategy for identification of TCM preparations containing natural and artificial musk.

Authors:  Meng Ding; Jun-Li Fan; Dong-Fang Huang; Yue Jiang; Meng-Ning Li; Yu-Qing Zheng; Xiao-Ping Yang; Ping Li; Hua Yang
Journal:  Chin Med       Date:  2022-04-01       Impact factor: 5.455

6.  Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study.

Authors:  Aayah Nounu; Siddhartha P Kar; Caroline L Relton; Rebecca C Richmond
Journal:  Breast Cancer Res       Date:  2022-10-08       Impact factor: 8.408

Review 7.  Do Dehydroepiandrosterone (DHEA) and Its Sulfate (DHEAS) Play a Role in the Stress Response in Domestic Animals?

Authors:  Gianfranco Gabai; Paolo Mongillo; Elisa Giaretta; Lieta Marinelli
Journal:  Front Vet Sci       Date:  2020-10-26

8.  The Relationships Between Serum DHEA-S and AMH Levels in Infertile Women: A Retrospective Cross-Sectional Study.

Authors:  Li-Te Lin; Kuan-Hao Tsui
Journal:  J Clin Med       Date:  2021-03-15       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.